NA

HIBSAGO (bepirovirsen) Medical Education

US Medical Affairs provides evidence-based scientific information and educational materials for US healthcare professionals.

Hibsago (bepirovirsen) Mechanism of Action

Hibsago (bepirovirsen) is an antisense oligonucleotide designed to target hepatitis B virus (HBV). This animated overview depicts the mechanism of action of bepirovirsen and its interaction with HBV-associated biological processes.

Transcript

Results

Hepatology

Key Topics

Content Type

    Hibsago (bepirovirsen) Scientific Resources

      

    Chronic Hepatitis B (CHB) Resources

      

    We couldn't find any matches!

    Please check the spelling or try searching something else

    You are now leaving GSK’s website

    This webinar was developed by the Coalition for Global Hepatitis Elimination and is supported by GSK. GSK had no input on webinar content or speakers.

    This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

    CANCEL  ACCEPT